Table 3.
SBP (mmHg) | DBP (mmHg) | Waist (cm) | FG (mmol/L) | TG (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | hs-CRP (mg/L) | IL-6 (pg/mL) | |
---|---|---|---|---|---|---|---|---|---|
TNM stages | −0.09 | 0.01 | −0.12 | 0.17* | − 0.01 | − 0.10 | − 0.11 | 0.22* | 0.35* |
Antioxidant vitamins status2 | |||||||||
β-carotene / LDL-C ≥ 81.3 nmol/mmol | 0.02 | 0.01 | −0.22* | 0.02 | −0.20* | −0.32* | − 0.05 | 0.08 | 0.06 |
Vitamin A / LDL-C ≥ 1.3 μmol/mmol | 0.02 | −0.04 | − 0.08 | 0.06 | 0.13 | −0.56* | 0.01 | −0.13 | 0.01 |
Vitamin E / LDL-C ≥ 9.5 μmol/mmol | 0.13 | 0.13 | −0.11 | 0.12 | 0.16 | −0.45* | −0.09 | 0.07 | 0.17 |
Ubiquinone / LDL-C ≥ 102.0 nmol/mmol | 0.08 | 0.03 | 0.00 | 0.07 | −0.18* | −0.26* | 0.30* | −0.01 | − 0.03 |
1 The data in this table were analyzed by Spearman’s rank order correlation. r, Spearman correlation coefficients. 2 Antioxidant vitamins status were stratified by the median value of all subjects. *p < 0.05. DBP, diastolic blood pressure; FG, fasting glucose; HDL-C, high-density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; IL-6, interleukin-6; LDL-C, low density lipoprotein-cholesterol; SBP, systolic blood pressure. TG, triglyceride; TNM, tumor-node-metastasis